Talquetamab  - multiple myeloma after at least three prior lines of therapy

Bull Cancer. 2024 Mar 7:S0007-4551(24)00049-3. doi: 10.1016/j.bulcan.2023.12.014. Online ahead of print.NO ABSTRACTPMID:38458925 | DOI:10.1016/j.bulcan.2023.12.014

Source: Bulletin du Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Thomas Fatrara Emilie Chalayer Source Type: research